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Human neutrophils generate a respiratory burst witb the elaboration of toxic oxygen metabolites upon 
appropriate stimulation. Su~uent to receptor-ligand interaction, the activation pathway of this burst 
is unknown. Here, attempts to correlate phospholipid turnover have demonstrated dissociation of lipid 
flux and burst activation. Quinacrine inhibited membrane depolarization, superoxide (0:) generation, and 
net phosphatidyls~ine production with I&-vahres of 16&M, 73 FM and >SOO~M, respectively. The 
inhibitory profiles of these neutrophil activation parameters demonstrate a dissociation between 
membrane depoiarization, respiratory burst stimulation, and phospholipid turnover. 
eutrophic ~inacr~ne Respiratory burst 
1. INTRODU~ION 
The generation of the respiratory burst in the 
human neutrophil by either phagocytosable par- 
ticles or soluble agonists results in the elaboration 
of toxic oxygen metabolites [ll. The metabolic ap- 
paratus responsible for this activity includes the ac- 
tivation of a partially characterized NADPH- 
oxidase [Z], whose activation pathway is unknown 
[3]. Associative parameters of neutrophil stimula- 
tion include the dose-dependent depolarization of 
the neutrop~ plasma membrane potential [4-6], 
and a rapid flux in lipid metabolism [T-12]. 
Mobilization of arachidonic acid by the activation 
of phospholip~es, and the extensive turnover of 
membrane phospholipids during phagocytosis, are 
associative metabolic activities, which have not as 
yet been integrated into a coherent schema for a 
neutrophil activation sequence. Phospholipid 
methylation and phospholipase AZ activation ap- 
pear requisite for chemotaxis, but the relationship 
of these activities to membrane depolarization and 
the activation of the burst is unclear [9,10]. 
thought capable of blocking release of fatty acids 
from phospholipids as a consequence of 
phospho~p~e AZ activation (reviewed in f13j). 
Quinacrine, however, may bind directly to 
phospholipids, forming less polar derivatives a d 
% thus perturbing membrane structure aud functio , 
rather than directly inhibiting phospholip~e [lZ& 
Here, we co&ii that quinacrine alters membrane 
function as measured by the depol~tion of the 
plasma membr~e, and the activation of the 
respiratory burst, but without inhibiting 
phospholipid turnover, sugg~ting a ~ss~iati~n 
of phospho~pid turnover from these other 
parameters of neutrophil stimulation. 
2. MATERIALS AND METHODS 
We have examined the i~ibition of human 
neutrophil activation by quinacrine, an agent 
Ferricytochrome c, cytochalasin B, phor&l 
myristate acetate @MA), superoxide dismutase 
(SOD), NADPH, concanavalin A, and quinacrine 
were purchased from Sigma (St Louis MO). The 
fluorescent probe, di-S-C&(S) was the generous gift 
of Dr Alan Waggoner, Carnegie-Mellon Universi;ty 
(Pittsburgh MA). Organic solvents for HPLC were 
purchased from Waters Assoc. (Milford MA) and 
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analytic aqueous solvents (Mallinckrodt, St Louis 
MO) were filtered on a Millipore 0.22pm filter. 
[‘H]Phorbol-dibutyrate (PDBu) was purchased 
from New England Nuclear (Boston MA). 
Human neutrophils were harvested from normal 
donors and prepared to >95% homogeneity as in 
[2]. Oxygen consumption was assessed with a 
Yellow Springs Clark electrode oxygen monitor [2] 
and 02 production was quantitated by the con- 
tinuous assay of SOD-inhibitable cytochrome c 
reduction, in a thermostated Perkin-Elmer Model 
557 spectrophotometer, for intact cells [14] and for 
a 27000 x g particulate preparation used to 
measure NADPH-oxidase activity [2]. In ex- 
periments employing quinacrine, both sample and 
reference cuvettes contained equal quantities of the 
agent, which was preincubated with the cells for 
3 min at 37°C before stimulation with either PMA 
(1 pg/ml) alone or concanavalin A (50 pg/ml) 
(after 3 min preincubation with cytochalasin B 
(5 ,ug/ml)). Binding assays of [3H]PDBu were per- 
formed by described methods [14]. 
Quantitation of neutrophil phospholipids was 
performed by adaption of the high-pressure liquid 
chromatographic technique in [15]. Cells (5 x 10’ 
cells/ml), preincubated at 37°C in phosphate- 
buffered saline (containing 0.9 mM CaC12 and 
0.45 MgC12) [14] with or without quinacrine 
(lOO-500/1M) for 3 min were stimulated with 
PMA (1 /rg/ml). After l-3 min, the activation was 
terminated by adding the cell mixture to 7 vol. 
chloroform : methanol (2 : 1); this suspension was 
homogenized, filtered on Whatman no.4 filter 
paper (Whatman, England) and separated with 3 
saline washes. The residual lower phase was dried 
under nitrogen and resuspended in 1.0 ml 
chloroform; 5-15 pl was chromatographed on a 
Waters Assoc. (Milford MA) liquid chromato- 
graphic system consisting of a Model 272 gradient 
system, Model 450 Variable wavelength absor- 
bance detector (detection at 203 mM), and a 
Hewlett-Packard Model 3390A integrator. The 
Silica gel column, 30 cm x 4 mm i.d. Micro-Pak S 
I-10 column obtained from Varian Assoc. (Palo 
Alto CA), was developed with acetonitrile- 
methanol-85% phosphoric acid (130: 5 : 15, by 
vol.) at 1.0 ml/min at 21°C. Calibration of the 
system and quantitation with standard compounds 
was performed daily with phosphatidylserine (PS), 
phosphatidylinositol, phosphatidylethanolamine, 
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phosphatidylcholine, phosphatidyldimethyletha- 
nolamine, lysophosphatidylcholine and lysophos- 
phatidylethanolamine (LPE) (Sigma, St Louis 
MO); after use the column was washed successively 
with methanol-water (1: 1, v/v), methanol, di- 
chloromethane, hexane and stored in THF (Waters 
Assoc., Milford MA). Recovery was >85% as 
assessed by tracer experiments with [3H]LPE (New 
England Nuclear, Boston MA). 
Membrane potential changes were evaluated as 
in [4]; fluorescence of a lo6 cells/ml KRP suspen- 
sion equilibrated for < 5 min with 2 /IM di-S&(5) 
was monitored on a Perkin Elmer 650 SlO spec- 
trofluorimeter equipped with stirring and ther- 
mostating (37°C) devices. Quinacrine (5-200 PM) 
was added and 1.5 mln incubation time were 
allowed to elapse before PMA (1 pg/ml) was 
added. 
3. RESULTS AND DISCUSSION 
The neutrophil respiratory burst is inhibited 
by quinacrine, as assessed by both 02 production 
and oxygen consumption. A comparable dose- 
response was obtained with either PMA or con- 
canavalin A in both assays. PMA was used ex- 
clusively in subsequent studies (fig.1). (The IDSO 
for PMA was 73.7 f 24.6 pM (mean f SD, n = 7), 
in the 02 assay.) To determine if quinacrine’s in- 
hibitory effect was due to direct inhibition of the 
NADPH-oxidase, a 27000 x g particulate prepara- 
tion from PMA stimulated cells was studied. The 
1.50 for the 02-generating NADPH-oxidase was 
>2 mM and could not be determined accurately. 
(At 500/M quinacrine, 02 generation was in- 
hibited ~20% .) Thus the inhibitory effect of 
quinacrine appeared to occur at a step prior to 
NADPH-oxidase activation, rather than by inhibi- 
tion of the enzyme itself. Trypan blue exclusion in 
the presence of 500 PM quinacrine was within nor- 
mal limits (not shown), and thus direct cellular tox- 
icity could not account for inhibited respiratory 
burst activity. That the inhibition was not related 
to interference of ligand binding was suggested by 
the similar inhibitory profiles for distinct receptors 
and by normal binding of PDBu (an analogue of 
PMA with high specific binding) to the phorbol 
receptor (not shown). 
These findings inferred that the quinacrine in- 
hibition of the respiratory burst was at a site in the 
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activation sequence between receptor-ligand bin- 
ding and NADPH-oxidase stimulation. Since 
depolarization of the neutrophil’s membrane 
potential precedes detectable 02 production, the 
effect of quinacrine upon the depolarization was 
examined. As shown in table 1, which gives data 
from one of 4 similar expt, quinacrine has no ef- 
fect on the fluorescence of di-SG(5) in a cell free 
system, nor does it affect the resting fluorescence 
of di-SC&) loaded human neutrophils which 
reflects their resting membrane potential. It does, 
however, markedly di~nish the initial rate of 
depolarization (V,), the most sensitive parameter 
measuring early stimulus response [4]. The com- 
pound also reduces the maximal attainable 
depolarization (AF/Fo). The quinacrine IDSO dose 
(required to decrease the P&U-induced 
deflection by 5~~0} was 16.2 f 4.2 psM (mean 
f SD, n = 4), which is -With that required to 
reduce the ensuant formation of 02 by 50% 
(fig. 1). The membrane response is reduced by 75% 
with 50 ,uM quinacrine, and is not further decreas- 
ed by higher concentrations of the drug (fii.2). 
The respective quinacrine inhibitory profiles of OZ 
generation and membrane depolarization are suffi- 
Table 1 
Representative effect of quinacrine upon membrane 
depolarization of resting and Pi-s~ulated 
neutrophils 
Fop [Quina- Fib 
crine] 
GM) 
Vo” Delayd cdF/ 
(min) Fo),C 
6.7 0 6.6 18.4 0.3 1.47 
6.3 10 6.2 16.7 0.4 1.90 
7.7 20 7.4 10.7 0.5 1.20 
6.5 50 6.3 4.4 0.6 0.62 
8.0 200 8.7 5.3 0.8 0.82 
apb The fluorescence fhexc. 620, A emission, 670) before 
(Fo) and after (FI) addition of quinacrine (expressed 
in arbitrary units) 
V,, slope of initial fluorescence changes (arbitrary 
units), an accurate measure of initial 
stimulus-response 
Delay before onset of fluorescence change upon 
PMA stimulation (indicated in minutes) 
(AF/Fo),,,~, maximum relative depolarization 
(Ffinal - FNFo 
ciently disparate to suggest a complex association 
of these activation parameters, which are as yet to 
be defined, and further support the hypothesis that 
depolarization is a separate and d&sociable event 
in the stimulus response [4-61. 
In an attempt o relate phospholipid metabolism 
to the quinacrine effects on respiratory burst 
and depolarization, phospholipid turnover in resti g 
and stimulated neutrophils was examined. d e 
have adapted high-pressure liquid chromat - 
% graphic analysis for these studies, yielding rap’ 
and repr~u~ible qu~titation of several phospho- 
and lysophospho~pids, whose metabolism a$- 
companies the activation process and likely contri- 
butes to membrane fluidity changes and/or 
depolarization seen in the stimulated cell [7-121. 
Chromatograms of lipid extracts demonstrate@ 
changes in total phospho~pid composition whit& 
were both time- and stimulus-dependent. The most 
dramatic flux noted over the first 3 min of stimula- 
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Fig. 1, Quinacrine inhibition of 05 production by PM- 
stimulated neutrophils. The data is the mean and 
standard eviation from 4 expt performed as in sect&n 
2. The 100% value for 0; generation was 7.92 f 
1.3 nmol. lo6 cells-’ .min-’ (mean it SD) (rates 
measured at 2 min post-PMA addition). 
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Fig.2. Rate of initial fluorescence change (V,) of di- 
SCr(5) in PMA-stimulated cells. A representative 
experiment of quinacrine inhibition of plasma 
membrane depolarization, performed as in section 2. 
tion was a rise in phosphatidylserine (PS) as noted 
by radioisotope incorporation techniques [151. PS 
levels increased to 80% of maximum by 1 min 
stimulation and plateaued by 3 min, forming a net 
increase of 3.02 f 1.21 ng/lO’ cells (mean f SD, 
n = 4). Quinacrine at 500 pM inhibited PS forma- 
tion to 64.6 f 23.l’Ji’o (n = 4) of controls, while at 
100 PM, it did not inhibit PS generation at ail. The 
minimal 7-fold difference in IDso-values for phos- 
pholipid turnover and respiratory burst activation 
suggests that the burst inhibition by quinacrine is 
due to other unidentified intermediate activa- 
tion steps between receptor-ligand binding and 
NADPH-oxidase expression, possibly through 
non-specific plasma membrane pertubation, as 
suggested in platelets and erythrocytes [13]. 
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